BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Protagen AG Counts on Scienion AG Technology


4/19/2011 9:54:22 AM

Dortmund, Germany, April 19, 2011 / B3C newswire /- Protagen AG today announced that Scienion AG will produce protein microarray batches for the clinical validation of the proprietary biomarker panels of Protagen. The batch sizes will comprise more than 1000 arrays.

Additionally, both companies plan to jointly evaluate new platforms for multiplex analytics and to co-develop novel approaches up to proof-of-concept levels under a strategic partnership.

“For the multicenter, international clinical validation studies of our multiplex diagnostic markers for the early detection of multiple sclerosis and the differential diagnosis of prostate cancer it is essential to ensure a consistently high statistical reliability for diagnostic conclusions. Scienion’s sciFLEXARRAYER technology – worldwide leading in nanodispensing – allows the manufacturing of protein microarray batches each with more than 3500 single proteins in highest quality and reproducibility”, comments Dr. Peter Schulz-Knappe, CSO of Protagen AG. “Thereby, we can realize the needed consistency in quality and properties throughout three stages: from spot to spot, from array to array and from batch to batch.”

“We are very pleased to welcome Protagen as a customer and partner for joint developments. The leading position of Protagen in providing high quality content for protein microarrays, and the UNIarray® concept for the development and validation of multiplex markers offers Scienion the possibility to perform feasibility studies close to the market and thus to demonstrate Scienion’s capacity and efficiency to new customers from the diagnostics and pharma industry“, states Dr. Holger Eickhoff, CEO of Scienion AG.

About Protagen AG - www.protagen.de

Protagen AG is an international leading specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis. The innovations of Protagen are UNIarray®, a technology platform for the development of novel serum based diagnostics, as well as UNIchip®, a versatile product family of protein microarrays for faster development of antibodies.

About Scienion - www.scienion.com

Scienion AG provides systems and services for the contact-free printing of biological and chemical agents for diagnostics, pharmaceutics, veterinary, plant and food analytics and research. Addressing the dynamically increasing needs for miniaturization and multiplex analyses, Scienion offers a unique technology portfolio that has been consequently expanded over one decade. Scienion provides flexible solutions for research and development whereas solutions for production purposes are rather customized. Systems and software are characterized by its versatility, precision and robustness. The company is a renowned specialist for ultra low volume liquid handling, particularly for the handling of precious and sensitive compounds of biological or chemical origin. Scienion’s dispensers allow for contact-free and precise drop spotting in the pico- to nano-liter range and are optimally suited for microarray based analytics – as for tests with DNA, oligonucleotides, peptides, proteins, antibodies, glycans or for dispensing cells onto various carriers.

The company operates from two sites, Dortmund and Berlin.

Contact

Dr. Stefan Müllner

CEO

Protagen AG

Otto-Hahn-Str. 15

44227 Dortmund

Phone: +49 (0) 231 9742 6300

Fax: +49 (0) 231 9742 6301

E-Mail: info@protagen.de

Media Enquiries

Bettina Franz

Protagen AG

Otto-Hahn-Str. 15

44227 Dortmund

Phone: +49 (0) 231 9742 6300

Fax: +49 (0) 231 9742 6301

E-Mail: bettina.franz@protagen.de

Contact Scienion AG

SCIENION AG

Almut Gebhard

Otto-Hahn-Str. 15

D-44227 Dortmund

Phone: +49 (0)30 - 6392 1700

Fax: +49 (0)30 - 6392 1701

E-Mail: gebhard@scienion.com

www.scienion.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES